Corvus Pharmaceuticals CRVS Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Corvus Pharmaceuticals’s reported figures.
The official record: Corvus Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Corvus Pharmaceuticals's enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Corvus Pharmaceuticals's enterprise value?
- Corvus Pharmaceuticals (CRVS) reported enterprise value of $1.19B in Q1 2026.
- How has Corvus Pharmaceuticals's enterprise value changed year-over-year?
- Corvus Pharmaceuticals's enterprise value increased by 458.9% year-over-year, from $212.83M to $1.19B.
- What is the long-term trend for Corvus Pharmaceuticals's enterprise value?
- Over 5 years (2020 to 2025), Corvus Pharmaceuticals's enterprise value has grown at a 30.4% compound annual growth rate (CAGR), from $151.57M to $571.41M.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.